MDAMMarraines D. Allaitement Maternel (French: Network of Breastfeeding Godmothers)
MDAMMillion Diamond Agency Manager
References in periodicals archive ?
MDAM (y-methylene-10-deazaaminopterin) is a novel antifolate that has a very broad spectrum of activity against human cancers in preclinical studies.
The Company's lead product, MDAM, for the treatment of solid tumors and rheumatoid arthritis is currently in Phase I clinical trials at The Johns Hopkins Oncology Center.
today announced that its anticancer drug MDAM, one of the first drugs designed and developed with the aid of supercomputers, has moved from concept to human clinical trials in rapid time and at reduced cost.